These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6752296)

  • 1. Antibody-independent activation of C1 by type Ia group B streptococci.
    Eads ME; Levy NJ; Kasper DL; Baker CJ; Nicholson-Weller A
    J Infect Dis; 1982 Nov; 146(5):665-72. PubMed ID: 6752296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
    Levy NJ; Kasper DL
    J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    Baker CJ; Edwards MS; Webb BJ; Kasper DL
    J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antibody and complement in opsonization of group B streptococci.
    Shigeoka AO; Hall RT; Hemming VG; Allred CD; Hill HR
    Infect Immun; 1978 Jul; 21(1):34-40. PubMed ID: 101462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspirin on the complement system in vitro.
    Hänsch GM; Voigtländer V; Rother U
    Int Arch Allergy Appl Immunol; 1980; 61(2):150-8. PubMed ID: 7351347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the complement system by antibody-antigen complexes: the classical pathway.
    Porter RR; Reid KB
    Adv Protein Chem; 1979; 33():1-71. PubMed ID: 396780
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
    Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
    J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of virulence by group B streptococcal polysaccharides.
    Levy NJ; Nicholson-Weller A; Baker CJ; Kasper DL
    J Infect Dis; 1984 Jun; 149(6):851-60. PubMed ID: 6376652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
    Gronski P; Bodenbender L; Kanzy EJ; Piepenbrock M; Seiler FR
    Immunobiology; 1986 Apr; 171(3):252-62. PubMed ID: 3011651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2.
    Yaseen S; Demopulos G; Dudler T; Yabuki M; Wood CL; Cummings WJ; Tjoelker LW; Fujita T; Sacks S; Garred P; Andrew P; Sim RB; Lachmann PJ; Wallis R; Lynch N; Schwaeble WJ
    FASEB J; 2017 May; 31(5):2210-2219. PubMed ID: 28188176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
    Saint-Remy JM
    Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.
    Vanguri P; Koski CL; Silverman B; Shin ML
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3290-4. PubMed ID: 6954480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1.
    Levy NJ; Kasper DL
    Infect Immun; 1985 Jul; 49(1):19-24. PubMed ID: 3891622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for an additional serum factor essential for the antibody-independent activation of the classical complement sequence by Gram-negative bacteria.
    Clas F; Loos M
    Infect Immun; 1982 Sep; 37(3):935-9. PubMed ID: 6752030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the classical complement pathway in human serum by a small oligosaccharide.
    Dieminger L; Schultz DR; Arnold PI
    J Immunol; 1979 Nov; 123(5):2201-11. PubMed ID: 489979
    [No Abstract]   [Full Text] [Related]  

  • 19. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
    Jacks-Weis J; Kim Y; Cleary PP
    J Immunol; 1982 Apr; 128(4):1897-902. PubMed ID: 7037956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.